Cited by 770Bipolar Disorder and TreatmentTreatment of Major DepressionSchizophrenia research and treatment

The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

Open access
Pacchiarotti, Isabella, Bond, David J., Baldessarini, Ross J., Nolen, Willem A., Grunze, Heinz, Licht, Rasmus W., Post, Robert M., Berk, Michael +59 more·2013·American Journal of Psychiatry

Abstract

OBJECTIVE: The risk-benefit profile of antidepressant medications in bipolar disorder is controversial. When conclusive evidence is lacking, expert consensus can guide treatment decisions. The International Society for Bipolar Disorders (ISBD) convened a task force to seek consensus recommendations on the use of antidepressants in bipolar disorders. METHOD: An expert task force iteratively developed consensus through serial consensus-based revisions using the Delphi method. Initial survey items were based on systematic review of the literature. Subsequent surveys included new or reworded items and items that needed to be rerated. This process resulted in the final ISBD Task Force clinical recommendations on antidepressant use in bipolar disorder. RESULTS: There is striking incongruity between the wide use of and the weak evidence base for the efficacy and safety of antidepressant drugs in bipolar disorder. Few well-designed, long-term trials of prophylactic benefits have been conducted, and there is insufficient evidence for treatment benefits with antidepressants combined with mood stabilizers. A major concern is the risk for mood switch to hypomania, mania, and mixed states. Integrating the evidence and the experience of the task force members, a consensus was reached on 12 statements on the use of antidepressants in bipolar disorder. CONCLUSIONS: Because of limited data, the task force could not make broad statements endorsing antidepressant use but acknowledged that individual bipolar patients may benefit from antidepressants. Regarding safety, serotonin reuptake inhibitors and bupropion may have lower rates of manic switch than tricyclic and tetracyclic antidepressants and norepinephrine-serotonin reuptake inhibitors. The frequency and severity of antidepressant-associated mood elevations appear to be greater in bipolar I than bipolar II disorder. Hence, in bipolar I patients antidepressants should be prescribed only as an adjunct to mood-stabilizing medications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2013.13020185

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [7]National Collaborating Centre for Mental Health: Bipolar Disorder The Management of Bipolar Disorder in Adults, Children, and Adolescents, in Primary and Secondary Care 2006 Leicester, UK British Psychological Society 21796830
  2. [98]Fiedorowicz JG Keller MB Coryell WH Endicott J Leon AC Treatment effectiveness and safety in the longitudinal course of mood disorders The Collaborative Depression Study: What Clinicians Need to Know Washington, DC American Psychiatric Publishing (in press)

Cited by

Sorted by citations

Authors
Pacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., Post, R. M., Berk, M., Goodwin, G. M., Sachs, G. S., Tondo, L., Findling, R. L., Youngstrom, E. A., Tohen, M., Undurraga, J., González-Pinto, A., Goldberg, J. F., Yildiz, A., Altshuler, L. L., Calabrese, J. R., Mitchell, P. B., Thase, M. E., Koukopoulos, A., Colom, F., Frye, M. A., Malhi, G. S., Fountoulakis, K. N., Vázquez, G., Perlis, R. H., Ketter, T. A., Cassidy, F., Akiskal, H., Azorin, J.-M., Valentí, M., Mazzei, D. H., Lafer, B., Kato, T., Mazzarini, L., Martínez-Aran, A., Parker, G., Souery, D., Özerdem, A., McElroy, S. L., Girardi, P., Bauer, M., Yatham, L. N., Zarate, C. A., Nierenberg, A. A., Birmaher, B., Kanba, S., El-Mallakh, R. S., Serretti, A., Rihmer, Z., Young, A. H., Kotzalidis, G. D., MacQueen, G. M., Bowden, C. L., Ghaemi, S. N., Lopez-Jaramillo, C., Rybakowski, J., Ha, K., Perugi, G., Kasper, S., Amsterdam, J. D., Hirschfeld, R. M., Kapczinski, F., & Vieta, E.
Affiliations
  • Universidade Federal do Rio Grande do Sul (BR)
  • From the Bipolar Disorders Program, Clinical Institute of Neuroscience, Hospital Clinic Barcelona, IDIBAPS (Institute of Biomedical Research August Pi i Sunyer), CIBERSAM (Center for Biomedical Research Network on Mental Health), University of Barcelona, Barcelona, Spain; Mood Disorders Centre, Department of Psychiatry, University of British Columbia, Vancouver; Department of Psychiatry, Harvard Medical School, Boston; Department of Psychiatry, University Medical Center Groningen, University of Groningen...
Venue
American Journal of Psychiatry
Published
2013-11
Volume
170
Issue
11
Pages
1249-1262
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2114807890
Cited by
770
References
104
Citations by year
2026: 43 · 2025: 47 · 2024: 42 · 2023: 47 · 2022: 46 · 2021: 53 · 2020: 60 · 2019: 65 · 2018: 59 · 2017: 67 · 2016: 67 · 2015: 89 · 2014: 80 · 2013: 4 · 2012: 1
FWCI
56.88
Type
journal article
Language
en
Open access
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • National Institutes of Health (Z99 MH999999)
  • Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
bipolar disorder, antidepressant use, antidepressant-induced mania, mood switching, mixed states, serotonin reuptake inhibitors, bupropion, tricyclic antidepressants, tetracyclic antidepressants, bipolar I disorder, bipolar II disorder, mood stabilizers, antidepressant safety, clinical guidelines
MeSH terms
Suicide Prevention, Affect, Antidepressive Agents, Bipolar Disorder, Delphi Technique, Humans, Suicide, Treatment Outcome, Advisory Committees, Consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review